Detection of Crimean-Congo Haemorrhagic Fever cases in a severe undifferentiated febrile illness outbreak in the Federal Republic of Sudan: A retrospective epidemiological and diagnostic cohort study.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
07 2019
Historique:
received: 25 02 2019
accepted: 22 06 2019
revised: 22 07 2019
pubmed: 11 7 2019
medline: 24 12 2019
entrez: 11 7 2019
Statut: epublish

Résumé

Undifferentiated febrile illness (UFI) is one of the most common reasons for people seeking healthcare in low-income countries. While illness and death due to specific infections such as malaria are often well-quantified, others are frequently uncounted and their impact underappreciated. A number of high consequence infectious diseases, including Ebola virus, are endemic or epidemic in the Federal Republic of Sudan which has experienced at least 12 UFI outbreaks, frequently associated with haemorrhage and high case fatality rates (CFR), since 2012. One of these occurred in Darfur in 2015/2016 with 594 cases and 108 deaths (CFR 18.2%). The aetiology of these outbreaks remains unknown. We report a retrospective cohort study of the 2015/2016 Darfur outbreak, using a subset of 65 of 263 outbreak samples received by the National Public Health Laboratory which met selection criteria of sufficient sample volume and epidemiological data. Clinical features included fever (95.8%), bleeding (95.7%), headache (51.6%) and arthralgia (42.2%). No epidemiological patterns indicative of person-to-person transmission or health-worker cases were reported. Samples were tested at the Public Health England Rare and Imported Pathogens Laboratory using a bespoke panel of likely pathogens including haemorrhagic fever viruses, arboviruses and Rickettsia, Leptospira and Borrelia spp. Seven (11%) were positive for Crimean-Congo haemorrhagic fever virus (CCHFV) by real-time reverse transcription PCR. The remaining samples tested negative on all assays. CCHFV is an important cause of fever and haemorrhage in Darfur, but not the sole major source of UFI outbreaks in Sudan. Prospective studies are needed to explore other aetiologies, including novel pathogens. The presence of CCHFV has critical infection, prevention and control as well as clinical implications for future response. Our study reinforces the need to boost surveillance, lab and investigative capacity to underpin effective response, and for local and international health security.

Sections du résumé

BACKGROUND
Undifferentiated febrile illness (UFI) is one of the most common reasons for people seeking healthcare in low-income countries. While illness and death due to specific infections such as malaria are often well-quantified, others are frequently uncounted and their impact underappreciated. A number of high consequence infectious diseases, including Ebola virus, are endemic or epidemic in the Federal Republic of Sudan which has experienced at least 12 UFI outbreaks, frequently associated with haemorrhage and high case fatality rates (CFR), since 2012. One of these occurred in Darfur in 2015/2016 with 594 cases and 108 deaths (CFR 18.2%). The aetiology of these outbreaks remains unknown.
METHODOLOGY/PRINCIPAL FINDINGS
We report a retrospective cohort study of the 2015/2016 Darfur outbreak, using a subset of 65 of 263 outbreak samples received by the National Public Health Laboratory which met selection criteria of sufficient sample volume and epidemiological data. Clinical features included fever (95.8%), bleeding (95.7%), headache (51.6%) and arthralgia (42.2%). No epidemiological patterns indicative of person-to-person transmission or health-worker cases were reported. Samples were tested at the Public Health England Rare and Imported Pathogens Laboratory using a bespoke panel of likely pathogens including haemorrhagic fever viruses, arboviruses and Rickettsia, Leptospira and Borrelia spp. Seven (11%) were positive for Crimean-Congo haemorrhagic fever virus (CCHFV) by real-time reverse transcription PCR. The remaining samples tested negative on all assays.
CONCLUSIONS/SIGNIFICANCE
CCHFV is an important cause of fever and haemorrhage in Darfur, but not the sole major source of UFI outbreaks in Sudan. Prospective studies are needed to explore other aetiologies, including novel pathogens. The presence of CCHFV has critical infection, prevention and control as well as clinical implications for future response. Our study reinforces the need to boost surveillance, lab and investigative capacity to underpin effective response, and for local and international health security.

Identifiants

pubmed: 31291242
doi: 10.1371/journal.pntd.0007571
pii: PNTD-D-19-00284
pmc: PMC6645580
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0007571

Déclaration de conflit d'intérêts

I have read the journal's policy and the authors of this manuscript have the following competing interests: HB, BG, JW & DB are members of the UK Public Health Rapid Support Team. AS, NJB, RH, SD and TB are affiliated to the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections at University of Liverpool in partnership with PHE, in collaboration with the Liverpool School of Tropical Medicine. The views expressed are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, the Department of Health and Social Care, or Public Health England.

Références

Clin Microbiol Infect. 2018 Aug;24(8):808-814
pubmed: 29454844
Virol J. 2017 Aug 3;14(1):147
pubmed: 28774342
Arch Virol. 2017 Mar;162(3):721-725
pubmed: 27878461
Pan Afr Med J. 2014 May 03;18:13
pubmed: 25360197
Int J Infect Dis. 2017 May;58:82-89
pubmed: 28259724
PLoS Negl Trop Dis. 2011;5(5):e1159
pubmed: 21655310
Clin Microbiol Infect. 2018 Aug;24(8):815-826
pubmed: 29581051
PLoS One. 2017 Sep 8;12(9):e0182315
pubmed: 28886039
Int J Infect Dis. 2015 Sep;38:19-23
pubmed: 26183415
Bull World Health Organ. 1978;56(2):271-93
pubmed: 307456
Clin Microbiol Infect. 2016 Apr;22(4):387.e1-387.e4
pubmed: 26806137
Emerg Infect Dis. 2010 May;16(5):837-9
pubmed: 20409377
Bull World Health Organ. 1978;56(2):247-70
pubmed: 307455
Virol J. 2006 Oct 12;3:85
pubmed: 17034648
N Engl J Med. 2013 Feb 21;368(8):689-91
pubmed: 23387798
Pediatr Infect Dis J. 2014 Aug;33(8):e194-7
pubmed: 24463803
PLoS Negl Trop Dis. 2015 Dec 03;9(12):e0004040
pubmed: 26633014
Euro Surveill. 2018 Dec;23(50):
pubmed: 30563591

Auteurs

Hilary Bower (H)

UK Public Health Rapid Support Team, London, United Kingdom.
Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Mubarak El Karsany (M)

Department of Medical Microbiology, Karary University, Khartoum, Sudan.
National Public Health Laboratory, Federal Ministry of Health, Khartoum, Sudan.

Mazza Alzain (M)

Communicable Disease Surveillance and Event Unit, Federal Ministry of Health, Khartoum, Sudan.

Benedict Gannon (B)

UK Public Health Rapid Support Team, London, United Kingdom.
Global Public Health, Public Health England, London, United Kingdom.

Rehab Mohamed (R)

National Public Health Laboratory, Federal Ministry of Health, Khartoum, Sudan.

Iman Mahmoud (I)

National Public Health Laboratory, Federal Ministry of Health, Khartoum, Sudan.

Mawahib Eldegail (M)

National Public Health Laboratory, Federal Ministry of Health, Khartoum, Sudan.

Rihab Taha (R)

National Public Health Laboratory, Federal Ministry of Health, Khartoum, Sudan.

Abdalla Osman (A)

National Public Health Laboratory, Federal Ministry of Health, Khartoum, Sudan.

Salim Mohamednour (S)

Communicable Disease Surveillance and Event Unit, Federal Ministry of Health, Khartoum, Sudan.

Amanda Semper (A)

National Infection Service, Public Health England, Porton, United Kingdom.

Barry Atkinson (B)

National Infection Service, Public Health England, Porton, United Kingdom.

Daniel Carter (D)

National Infection Service, Public Health England, Porton, United Kingdom.

Stuart Dowall (S)

National Infection Service, Public Health England, Porton, United Kingdom.

Jenna Furneaux (J)

National Infection Service, Public Health England, Porton, United Kingdom.

Victoria Graham (V)

National Infection Service, Public Health England, Porton, United Kingdom.

Jack Mellors (J)

National Infection Service, Public Health England, Porton, United Kingdom.

Jane Osborne (J)

National Infection Service, Public Health England, Porton, United Kingdom.

Steven T Pullan (ST)

National Infection Service, Public Health England, Porton, United Kingdom.

Gillian S Slack (GS)

National Infection Service, Public Health England, Porton, United Kingdom.

Tim Brooks (T)

National Infection Service, Public Health England, Porton, United Kingdom.

Roger Hewson (R)

National Infection Service, Public Health England, Porton, United Kingdom.

Nicholas J Beeching (NJ)

Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Jimmy Whitworth (J)

UK Public Health Rapid Support Team, London, United Kingdom.
Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Daniel G Bausch (DG)

UK Public Health Rapid Support Team, London, United Kingdom.
Global Public Health, Public Health England, London, United Kingdom.
Department of Disease Control, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Tom E Fletcher (TE)

Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH